Tagged with

Sweden Changing demographics and revolutionary technological advancements are altering the structure of the medtech industry paving the way for Arjo, a global Swedish supplier of medical devices and solutions, to rise up to the challenge. CEO Joacim Lindoff discusses the journey after Arjo’s split from Getinge in 2017, the company’s revived…

Puerto Rico Merck (MSD outside of the USA) is celebrating its 70-year anniversary in Puerto Rico this year. Executive Managing Director Wendy Perry highlights the company’s extensive footprint on the island which includes commercial, manufacturing and clinical research operations. She stresses the importance of maintaining a strong commercial presence locally to address…

Sweden With chromatography having been invented in Uppsala, Sweden, it makes sense for GE Healthcare’s Life Science business to have its largest global manufacturing and R&D operations there. GE Healthcare Nordics President and CEO Lotta Ljungqvist gives an overview of the firm’s global portfolio and highlights the importance of Swedish operations…

Taiwan Mark Yang, CEO of GaleMed, elaborates on the medical device manufacturer’s transition from a privately-owned company to being acquired by private equity firm Nexus Point Capital. Yang goes on to explain the new strategic vision of becoming an R&D-driven solutions provider to globally leading medical device companies while simultaneously building…

Rankings The MEA market has reached $25B in value, growing at 8% CAGR; short term growth stood at 10% from 2017 to 2018. Saudi Arabia, the largest market in MEA at $8.2B in value, grew at 7% in value terms. Egypt, Algeria and UAE are other large markets that had double-digit…

MEA These 10 corporations represent 37% of the MEA market by value. Novo Nordisk’s USD 635M growth is mainly driven by Norditropin (somatropin), Victoza (liraglutide) & Saxenda (liraglutide) which have grown at 60%, 18% and 190% PPG respectively. Hikma’s USD 497M growth has been the fastest due to Remox (amoxicillin) and…

Sweden Ulf G Andersson, CEO of the Medeon Science Park in Malmö, the Nordic’s oldest science park exclusively focused on life sciences, gives an overview of the history of the park, highlights the Medeon’s competitive advantage. He also offers first insights in his strategy of placing Medeon at the heart of…

China Jin Wang, Partner and Co-leader of the McKinsey China Healthcare Practice, shares the wide-ranging scope of her focus on ‘Big Healthcare’ involving work with healthcare service providers and payers, and pharmaceutical and medical products; the holistic and impactful solutions McKinsey can offer to the complex problems their clients face; as well…

Opinion Sophia Ononye outlines the history of cannabis as a medicine in the US and, following the first FDA approval of a cannabis-derived drug product in 2018, the highly promising landscape for further approvals.   The landscape for approved CBD products is highly promising and will undoubtedly lead to additional FDA…

Algeria Yacine Sellam examines how pharmacists in Algeria can follow the lead of their US counterparts and play a greater role in patients’ diabetes management.   Noncommunicable diseases are a growing burden in Algeria. The results of a STEPwise survey revealed that, for adults aged between 18 and 69 years, 23.6…

Taiwan United Biomedical, Inc. (UBI) is dedicated to the discovery, development, and commercialization of immunotherapies & vaccines for chronic and infectious diseases and is passionate about delivering science-driven innovation with platform capabilities. Chang Yi Wang is the Chairperson and CSO of United BioPharma (UBP), a member of the UBI group of…

Opinion The AAM’s Chip Davis tackles the issue of abandonment within US healthcare and proposes three measures to boost competition, thereby lowering drug prices and reducing abandonment rates.   Generic and biosimilar prescription drugs manufactured by member companies of the Association for Accessible Medicines (AAM) play an integral role in the…